Literature DB >> 16952923

Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents.

Simon J Corbett1, John Cosgrave, Gloria Melzi, Rade Babic, Giuseppe G L Biondi-Zoccai, Cosmo Godino, Nuccia Morici, Flavio Airoldi, Iassen Michev, Matteo Montorfano, Giuseppe M Sangiorgi, Erminio Bonizzoni, Antonio Colombo.   

Abstract

AIM: To evaluate patterns of restenosis following implantation of sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES) in comparable unselected lesions. METHODS AND
RESULTS: We have identified all episodes of restenosis after SES or PES implantation in our institutions between March 2003 and March 2005. Restenosis pattern was classified as focal, diffuse, proliferative, or occlusive. The position of focal restenosis was also categorized as proximal, in-stent, distal, or multi-focal. We have characterized 150 and 149 restenotic lesions in SES and PES groups, respectively. The incidence of diffuse and occlusive restenosis was significantly higher in PES than in SES (47.6 vs. 27.0%, P < 0.001). Multivariable (OR 2.693, 95% CI 1.425-5.089, P = 0.002) and propensity (OR 3.00, 95% CI 1.584-5.672, P < 0.001) analyses confirmed the positive association of PES with non-focal restenosis. For both stents, focal-edge restenosis was significantly more likely to occur proximally than distally (61.0 vs. 16.9%, P < 0.001 for PES and 45.8 vs. 16.8%, P < 0.001 for SES).
CONCLUSION: Focal restenosis remains the most common pattern with SES. In contrast, just under half of restenosis in PES is the more severe non-focal pattern. Paradoxically, the majority of focal restenosis occurs at the proximal stent margin for both platforms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16952923     DOI: 10.1093/eurheartj/ehl229

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

1.  Difference in neointimal coverage at chronic stage between bare metal stent and sirolimus-eluting stent evaluated at stent-strut level by optical coherence tomography.

Authors:  Shinichiro Ikuta; Kazuhiro Kobuke; Yoshitaka Iwanaga; Yoshifumi Nakauchi; Kenji Yamaji; Shunichi Miyazaki
Journal:  Heart Vessels       Date:  2013-06-21       Impact factor: 2.037

2.  Intravascular optical coherence tomography [Invited].

Authors:  Brett E Bouma; Martin Villiger; Kenichiro Otsuka; Wang-Yuhl Oh
Journal:  Biomed Opt Express       Date:  2017-04-26       Impact factor: 3.732

3.  A case of lipid core plaque progression and rupture at the edge of a coronary stent: elucidating the mechanisms of drug-eluting stent failure.

Authors:  Sergio Waxman; Mark I Freilich; Melissa J Suter; Milen Shishkov; Seth Bilazarian; Renu Virmani; Brett E Bouma; Gary J Tearney
Journal:  Circ Cardiovasc Interv       Date:  2010-04       Impact factor: 6.546

4.  Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options.

Authors:  Paolo Izzo; Andrea Macchi; Luisa De Gennaro; Antonio Gaglione; Matteo Di Biase; Natale Daniele Brunetti
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-06

5.  Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.

Authors:  Yufeng Yao; Zhenkun Hu; Jian Ye; Changqing Hu; Qixue Song; Xingwen Da; Yubin Yu; Hui Li; Chengqi Xu; Qiuyun Chen; Qing Kenneth Wang
Journal:  J Am Heart Assoc       Date:  2017-06-25       Impact factor: 5.501

6.  In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes.

Authors:  Ganesh Paramasivam; Tom Devasia; Ashwal Jayaram; Abdul Razak U K; M Sudhakar Rao; Rajesh Vijayvergiya; Krishnananda Nayak
Journal:  Anatol J Cardiol       Date:  2020-01       Impact factor: 1.596

7.  In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario.

Authors:  Ganesh Paramasivam; Tom Devasia; Shabeer Ubaid; Ashwitha Shetty; Krishnananda Nayak; Umesh Pai; Mugula Sudhakar Rao
Journal:  Egypt Heart J       Date:  2019-11-27

8.  Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis.

Authors:  Hyung Joon Joo; Han Saem Jeong; Hyungdon Kook; Seung Hun Lee; Jae Hyoung Park; Soon Jun Hong; Cheol Woong Yu; Do-Sum Lim
Journal:  BMC Cardiovasc Disord       Date:  2018-06-11       Impact factor: 2.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.